Smith Group Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Smith Group Asset Management’s Portfolio NBIX Stock Details NBIX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$375K	Buy
2025 Q3	$317K	Buy
2024 Q2	–	Sell
2024 Q1	$6.64M	Sell
2023 Q4	$9.02M	Buy
2016 Q2	–	Sell
2016 Q1	$701K	Sell
2015 Q4	$1.01M	Buy